Number of UK biotech companies rising, says report
A report has found that the number of life sciences companies domiciled in the UK has grown by nearly a quarter in the last few years.
Newsletters and Deep Dive digital magazine
A report has found that the number of life sciences companies domiciled in the UK has grown by nearly a quarter in the last few years.
Novartis is set to expand the label for its oral BTK inhibitor Rhapsido, keeping the drug on course to become one of its biggest-ever brands.
January was a relatively quiet month for Board news, but there were some notable moves here and there.
Volunteers with schizophrenia, bipolar, and depression will take part in an NHS study that will use genetic and health data to find new therapies.
Editor-in-chief Jonah Comstock sat down with pharmaphorum web editor Nicole Raleigh to discuss JPM2026.
Editor's Picks
Newsletters and Deep Dive
digital magazine